Human TNFRSF19 Gene cDNA Clone / ORF Clone (Cytokine)

Catalog	Vector (Price)	Quantity	In Stock	Operation
HG13387-G	Cloning vector ($95) pCMV / hygro ($295) pCMV / hygro - HA ($295) pCMV / hygro - His ($295) pCMV / hygro - Myc ($295) pCMV / hygro - FLAG ($295)		YES
* pCMV vectors are ALL featured with a CMV promoter and a hygromycin-resistance (hygro) gene. These plasmids can be used directly in mammalian cell expression. Learn more about pCMV vectors. Notice: Additional handling time(2-3 weeks) may be required if a pCMV vector is selected.

TNFRSF19 cDNA Clone Datasheet

TNFRSF19 cDNA Clone Product Information

Gene Bank Ref.ID:	NM_148957.3
cDNA Size:	1253
Gene Synonym:	TAJ; TROY; TRADE; TAJ-alpha; TNFRSF19
Source:	Human

TNFRSF19 cDNA Clone Description

cDNA Description:	ORF Clone of Homo sapiens tumor necrosis factor receptor superfamily, member 19 DNA.
Vector:	Cloning Vector: pGEM-T Vector Expression Vectors: pCMV/hygro, pCMV/hygro-Myc, pCMV/hygro-His, pCMV/hygro-HA, pCMV/hygro-FLAG
Sequence Description:	Same as Gene Bank Ref. ID sequence with the nucleotide 1 A deletion mutation and the point mutation 624 A/G，1209 T/C not causing the amino acid variation.

TNFRSF19 cDNA Clone Shipping

5-10μg Plasmid DNA is shipped on Whatman FTA elute card (Cat. No.: WB120410) at room temperature.
It would take 7-14 days for delivery typically. For bulk orders, additional 1-2 weeks would be needed.

TNFRSF19 cDNA Clone Usage Protocol

Cut along the circle edge of the spot (arrow points to) to get the filter paper.
Transfer the filter paper to a 1.5ml microfuge tube containing 150-200 μl of sterile H₂O Ensure the filter is completely immersed in the H₂O by briefly centrifuging the tube for 10 seconds.
Transfer the tube to incubation at 95℃ for 15-30 min.
At the end of the incubation pulse vortex, or gently tap the tube.
Briefly centrifuge for 30 seconds, to separate the matrix from the elute. The elute now contains the purified DNA.

TNFRSF19 cDNA Clone Sequence and Quality Control

Sequence:

1        TGGCTTTAAA AGTGCTACTA GAACAAGAGA AAACGTTTTT CACTCTTTTA GTATTACTAG
61       GCTATTTGTC ATGTAAAGTG ACTTGTGAAT CAGGAGACTG TAGACAGCAA GAATTCAGGG
121      ATCGGTCTGG AAACTGTGTT CCCTGCAACC AGTGTGGGCC AGGCATGGAG TTGTCTAAGG
181      AATGTGGCTT CGGCTATGGG GAGGATGCAC AGTGTGTGAC GTGCCGGCTG CACAGGTTCA
241      AGGAGGACTG GGGCTTCCAG AAATGCAAGC CCTGTCTGGA CTGCGCAGTG GTGAACCGCT
301      TTCAGAAGGC AAATTGTTCA GCCACCAGTG ATGCCATCTG CGGGGACTGC TTGCCAGGAT
361      TTTATAGGAA GACGAAACTT GTCGGCTTTC AAGACATGGA GTGTGTGCCT TGTGGAGACC
421      CTCCTCCTCC TTACGAACCG CACTGTGCCA GCAAGGTCAA CCTCGTGAAG ATCGCGTCCA
481      CGGCCTCCAG CCCACGGGAC ACGGCGCTGG CTGCCGTTAT CTGCAGCGCT CTGGCCACCG
541      TCCTGCTGGC CCTGCTCATC CTCTGTGTCA TCTATTGTAA GAGACAGTTT ATGGAGAAGA
601      AACCCAGCTG GTCTCTGCGG TCGCAGGACA TTCAGTACAA CGGCTCTGAG CTGTCGTGTT
661      TTGACAGACC TCAGCTCCAC GAATATGCCC ACAGAGCCTG CTGCCAGTGC CGCCGTGACT
721      CAGTGCAGAC CTGCGGGCCG GTGCGCTTGC TCCCATCCAT GTGCTGTGAG GAGGCCTGCA
781      GCCCCAACCC GGCGACTCTT GGTTGTGGGG TGCATTCTGC AGCCAGTCTT CAGGCAAGAA
841      ACGCAGGCCC AGCCGGGGAG ATGGTGCCGA CTTTCTTCGG ATCCCTCACG CAGTCCATCT
901      GTGGCGAGTT TTCAGATGCC TGGCCTCTGA TGCAGAATCC CATGGGTGGT GACAACATCT
961      CTTTTTGTGA CTCTTATCCT GAACTCACTG GAGAAGACAT TCATTCTCTC AATCCAGAAC
1021     TTGAAAGCTC AACGTCTTTG GATTCAAATA GCAGTCAAGA TTTGGTTGGT GGGGCTGTTC
1081     CAGTCCAGTC TCATTCTGAA AACTTTACAG CAGCTACTGA TTTATCTAGA TATAACAACA
1141     CACTGGTAGA ATCAGCATCA ACTCAGGATG CACTAACTAT GAGAAGCCAG CTAGATCAGG
1201     AGAGTGGCGC TGTCATCCAC CCAGCCACTC AGACGTCCCT CCAGGAAGCT TAA

Quality Control:cDNA sequencing results is available upon request.

TNFRSF19/TROY related areas, pathways, and other information

Cytokine